DaVita Clinical Research Presents Research Results at the 33rd Annual Dialysis Conference

  DaVita Clinical Research Presents Research Results at the 33rd Annual
  Dialysis Conference

Business Wire

SEATTLE -- March 13, 2013

DaVita Clinical Research^® (DCR^®), a specialty contract research organization
with services spanning the full spectrum of drug and device development,
presented research results at the 33rd Annual Dialysis Conference (ADC)  in
Seattle, March 9-12, 2013.

This international conference has become an influential annual meeting in the
dialysis and nephrology communities. The 2012 meeting attracted over 1,800
participants from more than 40countries.

Researchers from DaVita^®, the dialysis division of DaVita Healthcare Partners
Inc., and DCR presented results from a number of innovative clinical
improvement programs originating from DaVita and its research partners. DCR
provides a collaborative bridge between DaVita’s health care community and the
academic, pharmaceutical and biotech research community. DCR and DaVita share
a dedication to improving the health and quality of life for kidney care

“Our goal at DaVita is to try to improve our patients’ quality of life.
Research is a critical vehicle to achieve that end,” said Mahesh Krishnan,
M.D., M.P.H., M.B.A., F.A.S.N., vice president of clinical research. “The work
presented at ADC is intended to lead to better clinical outcomes and better
quality of life for chronic kidney disease and end-stage renal disease
patients around the world.”

ADC featured the following oral presentations by John Moran, M.D., F.A.C.P.,
vice president of medical affairs at DaVita:

  *Urgent-Start Peritoneal Dialysis: A Clinical Process Improvement Report –
    Monday, March 11. Slide Forum IV, Clinical Studies & Experiences Part B.
  *Implementation of Alcayis Protocol Markedly Improves Peritonitis Rates –
    Monday, March 11. Slide Forum IV, Clinical Studies & Experiences Part B.
  *Decreasing Peritonitis Rate in PD Resulting in Lower Mortality and
    Technique Failure – Monday, March 11. Slide Forum I, Quality Improvement.

ADC also featured the following poster presentation:

  *Association of Pruritis and Quality of Life (QOL) Among Patients at a
    Large Dialysis Provider (Bond TC, Mutell R, Wilfehrt HM, and Krishnan M.)
    – Sunday, March10. Poster Forum I, Quality Improvement.

DaVita, DaVita Clinical Research, DCR and DaVita HealthCare Partners are
trademarks or registered trademarks of DaVita Healthcare Partners Inc. All
other trademarks are the property of their respective owners.

About DaVita

DaVita is the dialysis division of DaVita HealthCare Partners Inc., a Fortune
500® company that, through its operating divisions, provides a variety of
health care services to patient populations throughout the United States and
abroad. A leading provider of kidney care in the United States, DaVita
delivers dialysis services to patients with chronic kidney failure and end
stage renal disease. DaVita strives to improve patients’ quality of life by
innovating clinical care, and by offering integrated treatment plans,
personalized care teams and convenient health-management services. As of Dec.
31, 2012, DaVita operated or provided administrative services at 1,954
outpatient dialysis centers located in the United States serving approximately
153,000 patients. The company also operated 36 outpatient dialysis centers
located in eight countries outside the United States. DaVita supports numerous
programs dedicated to creating positive, sustainable change in communities
around the world. The company’s leadership development initiatives and social
responsibility efforts have been recognized by Fortune, Modern Healthcare,
Newsweek and WorldBlu. For more information, please visit DaVita.com.

About DaVita Clinical Research

DaVita Clinical Research(DCR), a wholly owned subsidiary ofDaVita HealthCare
Partners, Inc., uses its extensive, applied database and real-world healthcare
experience to assist pharmaceutical and medical device companies in the
design, recruitment, and completion of clinical trials including retrospective
and prospective pragmatic trials.DCR’s scientific and clinical expertise
spans the lifecycle of product development with more than 150 client
companies. DCR’sBiorepository,Early Clinical Researchunit (Phase I-IIa)
andClinical Development (Phase IIb through post-marketing)network of
physicians and investigative sites, data research,Health Economics & Outcomes
Research,Central Laboratory, andMedical Communicationsare focused on
providing world-class research in both complex/specialty populations and
therapeutic areas, and especially in CKD and ESRD populations. To learn more
about DCR, visitwww.davitaclinicalresearch.com.


DaVita Clinical Research
Bianca Violante, 303-876-6614
Mobile: 443-417-6044
Press spacebar to pause and continue. Press esc to stop.